Desjardins, Clarissa,Grogan, Donna Roy,Packman, Jeffrey Neal,Harnett, Mark
申请号：
AU2017276835
公开号：
AU2017276835A1
申请日:
2017.06.08
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare- ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
